139 related articles for article (PubMed ID: 17453622)
21. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
[TBL] [Abstract][Full Text] [Related]
22. Heparan sulfate-protein interactions--a concept for drug design?
Lindahl U
Thromb Haemost; 2007 Jul; 98(1):109-15. PubMed ID: 17598000
[TBL] [Abstract][Full Text] [Related]
23. The workings of the amyloid diseases.
Bellotti V; Nuvolone M; Giorgetti S; Obici L; Palladini G; Russo P; Lavatelli F; Perfetti V; Merlini G
Ann Med; 2007; 39(3):200-7. PubMed ID: 17457717
[TBL] [Abstract][Full Text] [Related]
24. Roles of heparan sulfate in mammalian brain development current views based on the findings from Ext1 conditional knockout studies.
Yamaguchi Y; Inatani M; Matsumoto Y; Ogawa J; Irie F
Prog Mol Biol Transl Sci; 2010; 93():133-52. PubMed ID: 20807644
[TBL] [Abstract][Full Text] [Related]
25. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit.
Ancsin JB
Amyloid; 2003 Jun; 10(2):67-79. PubMed ID: 12964414
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of amyloidogenesis with Congo red in experimental amyloidosis].
Kagan DZ; Rozinova VN
Probl Tuberk; 1974; (9):72-4. PubMed ID: 4409858
[No Abstract] [Full Text] [Related]
27. Molecules that target beta-amyloid.
Stains CI; Mondal K; Ghosh I
ChemMedChem; 2007 Dec; 2(12):1674-92. PubMed ID: 17952881
[TBL] [Abstract][Full Text] [Related]
28. Anti-amyloid drugs: potential in the treatment of diseases associated with aging.
Kisilevsky R
Drugs Aging; 1996 Feb; 8(2):75-83. PubMed ID: 8845588
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate: a complex polymer charged with biological activity.
Whitelock JM; Iozzo RV
Chem Rev; 2005 Jul; 105(7):2745-64. PubMed ID: 16011323
[No Abstract] [Full Text] [Related]
30. Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
Hershkovitz O; Jarahian M; Zilka A; Bar-Ilan A; Landau G; Jivov S; Tekoah Y; Glicklis R; Gallagher JT; Hoffmann SC; Zer H; Mandelboim O; Watzl C; Momburg F; Porgador A
Glycobiology; 2008 Jan; 18(1):28-41. PubMed ID: 18006589
[TBL] [Abstract][Full Text] [Related]
31. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.
Kisilevsky R; Lemieux LJ; Fraser PE; Kong X; Hultin PG; Szarek WA
Nat Med; 1995 Feb; 1(2):143-8. PubMed ID: 7585011
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
[TBL] [Abstract][Full Text] [Related]
33. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
34. Heparan sulfates in skeletal muscle development and physiology.
Jenniskens GJ; Veerkamp JH; van Kuppevelt TH
J Cell Physiol; 2006 Feb; 206(2):283-94. PubMed ID: 15991249
[TBL] [Abstract][Full Text] [Related]
35. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O
J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
[TBL] [Abstract][Full Text] [Related]
36. [Amyloidosis: the biochemical nature of amyloid substance. Amyloidogenesis].
Sańchez Ramos JA; Superby Jeldres A; Pérez Peña F; Garcia Crespo P; Bárcenas Marugan F; Balsa Bretón A; Bárcenas Marugan A; Schüller Pérez A
Rev Clin Esp; 1982 Oct; 167(1):5-10. PubMed ID: 7178588
[No Abstract] [Full Text] [Related]
37. [Treatment of amyloidosis].
Wien TN
Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1397-400. PubMed ID: 18552901
[TBL] [Abstract][Full Text] [Related]
38. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
[TBL] [Abstract][Full Text] [Related]
39. The role of heparan sulphate in inflammation.
Parish CR
Nat Rev Immunol; 2006 Sep; 6(9):633-43. PubMed ID: 16917509
[TBL] [Abstract][Full Text] [Related]
40. [Heparan sulphates, amyloidosis and neurodegeneration].
Vera C; Alvarez-Orozco JA; Maiza A; Chantepie S; Chehin RN; Ouidja MO; Papy-Garcia D
Rev Neurol; 2017 Nov; 65(10):457-468. PubMed ID: 29130469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
